Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte bayer.com.Actuellement, hébergé dans Germany et son fournisseur de services est Oevermann Networks GmbH .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
IP:193.26.15.40 ASN:8422 OWNER:NETCOLOGNE, DE Country:DE
mx:
MX preference = 200, mail exchanger = smtpmx03.bayer.de. MX preference = 300, mail exchanger = smtpmx06.bayer.de. MX preference = 200, mail exchanger = smtpmx04.bayer.de. MX preference = 100, mail exchanger = smtpmx02.bayer.de. MX preference = 100, mail exchanger = smtpmx05.bayer.de. MX preference = 100, mail exchanger = smtpmx01.bayer.de.
HtmlToText
contact us deutsch global de search menu home this is bayer this is bayer bayer is a global enterprise with core competencies in the life science fields of health care and agriculture. overview overview profile and organization at a glance our strategy our values our brand pharmaceuticals consumer health crop science animal health business services currenta societal needs our contribution to a better life smart fields allergies a common disorder for the heart fit in old age defying the weather shrinking farmland living with dengue the future of agriculture and food bayer employees bayer worldwide overview europe, middle east & africa europe, middle east & africa german sites north america asia/pacific latin america websites worldwide procurement procurement at bayer strategy sustainability in procurement our approach supplier code of conduct industry initiatives supplier information monsanto acquisition conditions of purchase invoicing downloads & links corporate compliance policy transfers of value to healthcare professionals commitment collaboration with healthcare professionals facts on disclosure data disclosure cpsia information & it security corporate governance overview duties and activities of the board of management supervisory board disclosure of managers‘ transactions number of women in management positions control corporate compliance transparency links & downloads political engagement our political positions history overview 1863–1881 1881–1914 1914–1925 1925–1945 1945–1951 1951–1974 1974–1988 1988–2001 2001–2010 2010–2018 2013 – 150 years of bayer biographies the bayer cross the corporate archives board of management members werner baumann wolfgang nickl dr. hartmut klusik kemal malik dieter weinand heiko schipper liam condon offices held at other companies compensation supervisory board members committees compensation calendar current events archive contact us innovation innovation bayer is an innovation company with a more than 150-year history. our scientific successes are intended to help improve people’s lives. overview overview research at bayer overview health care nutrition technology open innovation leaps by bayer bayer lifescience ihub bayer at slush 2017 cube tech fair 2018 research – the bayer scientific magazine products products with our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition. overview overview product areas chempark management information for patients beware of medical counterfeits overview recognizing fakes background information recognizing fraudulent brands commitment to fighting counterfeit drugs news links counterfeits in agriculture overview regognize & avoid counterfeits bayer´s role in combating counterfeits bayer capseal & bayer capseal app report a side-effect products from a to z sustainability sustainability read more about our economic, ecological and social challenges and opportunities. overview overview strategy overview latest key data targets and performance indicators development un global compact key topics healthcare food security management and governance sustainability management stakeholder dialogue global commitment to sustainability bayer group regulations sustainable development policy corporate compliance policy supplier code of conduct responsible marketing & sales group regulation code of conduct for responsible lobbying bayer human rights position modern slavery act statement position on responsible care bayer positions un sustainable development goals position on global product strategy bayer water position bayer's position on the protection of biodiversity supplier management employees product stewardship overview drugs & medical products crop protection products & seeds antibiotics for animals partnerships safety environmental protection societal engagement overview education and research overview school support agricultural education student competitions baylabs making science make sense health and social needs overview fight against non-communicable diseases family planning ambassadors for contraception neglected tropical diseases disaster aid bayer scholarships bayer clubs sports bayer and sports successful bayer athletes history disabled sports paralympics 2016 promotion of new talent bayer 04 leverkusen culture bayer foundations international volunteering program overview china, yunnan german, berlin usa, lubbock colombia, bogotá france, lyon italy, milan kenya, chepkanga ukraine, kharkiv taichung report ratings, rankings and awards straight forward overview side effects of drugs safety of crop protection products access to medicine smallholder farmers bee health genetic engineering standards for clinical studies ethics in business practices use of water response to climate change suppliers animal studies: why? media media this area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the bayer group. overview overview news biographies board of management werner baumann wolfgang nickl dr. hartmut klusik kemal malik dieter weinand heiko schipper liam condon supervisory board werner wenning oliver zühlke speeches photos tv footage publications overview financial reports integrated annual reports quarterly reports magazines bayer magazine beenow magazine farming’s future magazine research magazine technology solutions magazine public health magazine brochures names | figures | facts from molecules to medicine from molecules to veterinary medicines brochure integrated weed management transfers of value to physicians brochure newsletter overview videos social media social media room social media channels apps events current archive media contact investors investors we want to create value for our shareholders through innovation, growth and high earning power. overview overview bayer group about bayer key figures profile and organization subsidiaries acquisitions and divestitures our products markets and economic outlook research & development bayer@social media brochure names figures facts brand & values strategic alignment group strategy strategies of the segments value-based performance outlook and targets opportunity and risk report corporate governance articles of incorporation board of management supervisory board sustainability and commitment stock investors key messages to investors new investors institutional investors private investors fixed income investors socially responsible investing listing and key figures basic data key figures share listings equity indices adr program share price current share price charts closing prices capital increase dividends profitability analysts consensus stockholders' portal ownership structure overview voting rights announcements archive voting rights announcements stock programs overview aspire participation program stock history glossary archive bonds overview financial strategy financial management liability mix maturity profile net financial debt credit default swaps funding instruments overview commercial paper programme syndicated loan facility bonds issued rating bond news credit analysts credit relations reports annual reports overview key figures comparison financial position income statement cashflow statement segment overview region overview five-year summary quarterly reports bayer ag financial statements sustainability reports archive annual stockholders’ meeting 2018 overview notice of the meeting & agenda overview item 1 item 2 item 3 item 4 item 5 stockholders countermotions and election proposals how to vote & stockholders’ portal voting results service overview important dates getting to the meeting stockholders’ hotline downloads archive events calendar live events q1 2018 conference call fy/q4 2017 conference call bayer to acquire monsanto investor conferences stockholders' meeting overview asm 2017 asm 2016 asm 2015 asm 2014 asm 2013 asm 2012 asm 2011 as
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR CSC Corporate Domains, Inc.
SERVERS
SERVER com.whois-servers.net
ARGS domain =bayer.com
PORT 43
TYPE domain RegrInfo DOMAIN
NAME bayer.com
CHANGED 2017-01-22
CREATED 1996-01-25
STATUS clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus
bayer.com rapport :
Visitez le site